152 related articles for article (PubMed ID: 8302843)
1. Exogenous Mtv-7 superantigen transgene expression in major histocompatibility complex class II I-E- mice reconstituted with embryonic stem cell-derived hematopoietic stem cells.
Chambers CA; Kang J; Pawling J; Huber B; Hozumi N; Nagy A
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1138-42. PubMed ID: 8302843
[TBL] [Abstract][Full Text] [Related]
2. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
[TBL] [Abstract][Full Text] [Related]
3. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
[TBL] [Abstract][Full Text] [Related]
4. Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule.
Wirth S; Vessaz A; Krummenacher C; Baribaud F; Acha-Orbea H; Diggelmann H
J Virol; 2002 Nov; 76(21):11172-5. PubMed ID: 12368363
[TBL] [Abstract][Full Text] [Related]
5. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
[TBL] [Abstract][Full Text] [Related]
6. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
7. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.
Waanders GA; Shakhov AN; Held W; Karapetian O; Acha-Orbea H; MacDonald HR
J Exp Med; 1993 May; 177(5):1359-66. PubMed ID: 8386743
[TBL] [Abstract][Full Text] [Related]
8. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
9. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection.
Golovkina TV; Dudley JP; Jaffe AB; Ross SR
Proc Natl Acad Sci U S A; 1995 May; 92(11):4828-32. PubMed ID: 7761408
[TBL] [Abstract][Full Text] [Related]
10. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
11. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
[TBL] [Abstract][Full Text] [Related]
12. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
[TBL] [Abstract][Full Text] [Related]
13. A novel exogenous mammary tumor virus encoding MHC class II H2E-independent superantigen specific for Tcr-V beta 14.
Wajjwalku W; Ando Y; Niimi N; Yoshikai Y
Immunogenetics; 1995; 41(2-3):156-8. PubMed ID: 7806290
[No Abstract] [Full Text] [Related]
14. Genetic analysis of the effects of Mtv-2 on the T cell repertoire in the WXG-2 mouse strain.
Ferrick DA; Cho K; Gemmell-Hori L; Morris DW
Int Immunol; 1992 Jul; 4(7):805-10. PubMed ID: 1323327
[TBL] [Abstract][Full Text] [Related]
15. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
Beutner U; McLellan B; Kraus E; Huber BT
Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
[TBL] [Abstract][Full Text] [Related]
16. I-J revisited: is the I-J genetic restriction in downregulation due to an endogenous superantigen analogous to mammary tumour virus (Mtv)-encoded endogenous superantigen?
Asherson GL; Dieli F; Tomonari K
Folia Biol (Praha); 1994; 40(6):341-7. PubMed ID: 7589693
[TBL] [Abstract][Full Text] [Related]
17. Identification of two V beta 7-specific viral superantigens.
Ignatowicz L; Kappler JW; Marrack P; Scherer MT
J Immunol; 1994 Jan; 152(1):65-71. PubMed ID: 8254207
[TBL] [Abstract][Full Text] [Related]
18. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
McMahon CW; Bogatzki LY; Pullen AM
Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
Waanders GA; Lees RK; Held W; MacDonald HR
Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
[TBL] [Abstract][Full Text] [Related]
20. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region.
Zhang DJ; Tsiagbe VK; Huang C; Thorbecke GJ
J Immunol; 1996 Oct; 157(8):3510-7. PubMed ID: 8871650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
